Predictions
Blue Apron Holdings Inc.
Start price
Target price
Perf. (%)
€59.86
22.08.22
22.08.22
€117.60
22.08.23
22.08.23
12.95%
05.09.22
05.09.22
Could be very worthwhile Investment >20% year
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€10.10
22.08.22
22.08.22
€10.00
22.08.23
22.08.23
-13.85%
23.08.22
23.08.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Bank of America Corp.
Start price
Target price
Perf. (%)
€35.10
21.08.22
21.08.22
-
21.08.23
21.08.23
-23.75%
21.08.23
21.08.23
Beyond Meat Inc
Start price
Target price
Perf. (%)
€29.31
21.08.22
21.08.22
-
21.08.23
21.08.23
-63.32%
22.08.23
22.08.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€10.10
21.08.22
21.08.22
-
21.08.23
21.08.23
-99.29%
22.08.23
22.08.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€76.50
21.08.22
21.08.22
€230.00
21.08.23
21.08.23
6.54%
04.09.22
04.09.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€214.90
21.08.22
21.08.22
€87.00
21.08.23
21.08.23
-3.44%
04.09.22
04.09.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Invitae Corp
Start price
Target price
Perf. (%)
€3.50
21.08.22
21.08.22
€1.00
21.08.23
21.08.23
-21.28%
04.09.22
04.09.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Home Depot Inc.
Start price
Target price
Perf. (%)
€321.00
20.08.22
20.08.22
-
20.08.23
20.08.23
-6.60%
21.08.23
21.08.23
Fair valuation
High dividend yield expected
Valuable balance sheet
Little Investments for future growth
STAG Industrial Inc.
Start price
Target price
Perf. (%)
€33.77
20.08.22
20.08.22
-
20.09.22
20.09.22
-7.45%
21.09.22
21.09.22
Could be worthwhile Investment >10% per year
Capable Management
Poxel S.A.
Start price
Target price
Perf. (%)
€2.49
20.08.22
20.08.22
-
20.08.23
20.08.23
-75.54%
07.06.23
07.06.23
Could be worthwhile Investment >10% per year
Phillips 66
Start price
Target price
Perf. (%)
€87.93
20.08.22
20.08.22
-
20.09.22
20.09.22
-5.35%
21.09.22
21.09.22
High dividend yield expected
Mediwound Ltd.
Start price
Target price
Perf. (%)
€2.00
19.08.22
19.08.22
-
19.08.23
19.08.23
470.00%
08.01.23
08.01.23
Risky Investment
Myovant Sciences Ltd
Start price
Target price
Perf. (%)
€17.50
19.08.22
19.08.22
-
19.08.23
19.08.23
-4.00%
26.08.22
26.08.22
Could be very worthwhile Investment >20% year
Canadian Solar Inc.
Start price
Target price
Perf. (%)
€43.81
19.08.22
19.08.22
€48.00
19.08.23
19.08.23
3.88%
25.08.22
25.08.22
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€10.52
19.08.22
19.08.22
-
19.08.27
19.08.27
-99.31%
12.01.24
12.01.24
Could be worthwhile Investment >10% per year
Small cyclical dependencies
Geovax Labs Inc.
Start price
Target price
Perf. (%)
€1.99
18.08.22
18.08.22
-
18.08.23
18.08.23
-16.16%
20.08.22
20.08.22
Risky Investment
Cyclacel Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.29
18.08.22
18.08.22
€7.00
18.08.23
18.08.23
-33.11%
22.08.22
22.08.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
EBIT growth >5% per year expected
Blue Apron Holdings Inc.
Start price
Target price
Perf. (%)
€67.58
18.08.22
18.08.22
€132.00
18.09.22
18.09.22
-11.43%
22.08.22
22.08.22
Could be very worthwhile Investment >20% year
Iberdrola S.A.
Start price
Target price
Perf. (%)
€10.95
18.08.22
18.08.22
€16.00
18.08.23
18.08.23
-3.88%
18.08.23
18.08.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High dividend yield expected
Top 10 in its market